CurrentRheuma
Get Weekly

Topic · page 18 of 40

Rheumatoid arthritis

Early and established rheumatoid arthritis in adults: diagnosis and prediction (clinically suspect arthralgia, people at risk), treat-to-target, conventional, biologic and targeted synthetic drugs, tapering and withdrawal, glucocorticoids, extra-articular disease and rheumatoid arthritis–associated interstitial lung disease

Briefs 681–720 of 1,564 placed here, newest publication first

Briefs in Rheumatoid arthritis

Newest publication first

  1. Rheumatology (Oxford)

    A multivariable prediction model to identify anti-CCP positive people in those with non-specific musculoskeletal symptoms in primary care

    Diagnostic or prognostic study

  2. Arthritis Rheumatol

    Metabolic Syndrome, Adipokines, and Response to Advanced Therapies in Rheumatoid Arthritis

    Cohort study

  3. J Rheumatol

    Exome Sequencing of Chinese Patients With Anticitrullinated Protein Antibody–Positive Rheumatoid Arthritis in Singapore

    Case-control study

  4. Arthritis Care Res (Hoboken)

    Escalation to Biologics After Methotrexate Among US Veterans With Rheumatoid Arthritis Grouped by Rural Versus Urban Areas

    Cohort study

  5. Scand J Rheumatol

    Incident rheumatoid arthritis in patients living in Turkey and in Denmark: a comparative clinical, genetic, and serological study

    Cohort study

  6. Clin Exp Rheumatol

    Application of vascular index based on superb microvascular imaging technique for assessing disease activity in rheumatoid arthritis patients with signal-positive joints

    Diagnostic or prognostic study

  7. Rheumatology (Oxford)

    Do SMS/e-mail reminders increase influenza vaccination of rheumatoid arthritis patients under anti-TNF: a nested randomized controlled trial in the ART e-cohort

    Randomized controlled trial

  8. Rheumatology (Oxford)

    A mobile app to support self-management and remotely monitor disease impact in rheumatoid arthritis: the randomized controlled AEGORA trial

    Randomized controlled trial

  9. RMD Open

    Biomechanical determinants of rheumatoid arthritis severity and excess cardiovascular disease: common origins of two complex diseases

    Cross-sectional study

  10. Arthritis Rheumatol

    Characterizing Nonarticular Pain at Early Rheumatoid Arthritis Diagnosis: Evolution Over the First Year of Treatment and Impact on Remission in a Prospective Real‐World Early Rheumatoid Arthritis Cohort

    Cohort study

  11. RMD Open

    Arthritis progressors have a decreased frequency of circulating autoreactive T cells during the at-risk phase of rheumatoid arthritis

    Mechanistic study

  12. Arthritis Rheumatol

    Evidence of Site‐Specific Mucosal Autoantibody Secretion in Rheumatoid Arthritis

    Cross-sectional study

  13. RMD Open

    Fibroblast-like synoviocyte targeting antibodies are associated with failure to reach early and sustained remission or low disease activity after first-line therapy in rheumatoid arthritis

    Diagnostic or prognostic study

  14. Semin Arthritis Rheum

    Smoking-related bias of standardized mortality ratios in rheumatoid arthritis: A modeling study

    Research article

  15. Arthritis Rheumatol

    Neutrophil Activation Markers and Rheumatoid Arthritis Treatment Response to the JAK1/2 Inhibitor Baricitinib

    Mechanistic study

  16. Scand J Rheumatol

    Mitophagy drives maldifferentiation of tissue-resident memory T cells in patients with rheumatoid arthritis

    Mechanistic study

  17. Joint Bone Spine

    Detecting new erosions in rheumatoid arthritis over one year – Radiography and high-resolution computed tomography of finger joints

    Diagnostic or prognostic study

  18. Ann Rheum Dis

    Association of rheumatoid factor, anti-citrullinated protein antibodies and shared epitope with clinical response to initial treatment in patients with early rheumatoid arthritis: data from a randomised controlled trial

    Secondary analysis

  19. Ann Rheum Dis

    Early identification of rheumatoid arthritis: does it induce treatment-related cost savings?

    Cohort study

  20. Ann Rheum Dis

    Helicobacter pylori upregulates PAD4 expression via stabilising HIF-1α to exacerbate rheumatoid arthritis

    Mechanistic study

  21. Ann Rheum Dis

    Positive feedback loop PU.1-IL9 in Th9 promotes rheumatoid arthritis development

    Mechanistic study

  22. Ann Rheum Dis

    Rheumatoid arthritis patients harbour aberrant enteric bacteriophages with autoimmunity-provoking potential: a paired sibling study

    Mechanistic study

  23. RMD Open

    Therapeutic serum level for adalimumab in rheumatoid arthritis: explorative analyses of data from a randomised phase III trial

    Secondary analysis

  24. Osteoporos Int

    First fracture in rheumatoid arthritis: analysis by fracture site, gender, age, and comorbidities

    Cohort study

  25. RMD Open

    Is rheumatoid arthritis always preceded by a symptomatic at-risk phase of arthralgia?

    Cohort study

  26. RMD Open

    Routine radiographs of hands and feet do not have diagnostic or prognostic value in patients with clinically suspect arthralgia: a large longitudinal study

    Cohort study

  27. Ann Rheum Dis

    Dynamics of the gut microbiome in individuals at risk of rheumatoid arthritis: a cross-sectional and longitudinal observational study

    Cross-sectional study

  28. Arthritis Res Ther

    Timely escalation to second-line therapies after failure of methotrexate in patients with early rheumatoid arthritis does not reduce the risk of becoming difficult-to-treat

    Cohort study

  29. Ann Rheum Dis

    Shared lung and joint T cell repertoire in early rheumatoid arthritis driven by cigarette smoking

    Mechanistic study

  30. Rheumatology (Oxford)

    Serum levels of free light chains and syndecan-1 in patients with rheumatoid arthritis and systemic lupus erythematosus

    Cross-sectional study

  31. RMD Open

    Remission versus low disease activity as treatment targets in rheumatoid arthritis: how to strike the right balance between too strict and too lenient targets? A meta-epidemiological study of individual patient data

    Meta-analysis

  32. Rheumatology (Oxford)

    Association between depression and anxiety and inability to achieve remission in rheumatoid arthritis and psoriatic arthritis

    Cohort study

  33. Rheumatology (Oxford)

    MUC5B promoter variant and survival in rheumatoid arthritis-associated interstitial lung disease

    Cohort study

  34. Rheumatology (Oxford)

    Predictors of the effectiveness of first-line CTLA4-Ig in patients with RA: the FIRST registry

    Cohort study

  35. Clin Exp Rheumatol

    Drug survival and predictor factors for discontinuation of first-line biologic therapy in rheumatoid arthritis: data from a real-world single-centre study

    Cohort study

  36. JAMA Netw Open

    Use of Biologic or Targeted Synthetic Disease-Modifying Antirheumatic Drugs and Cancer Risk

    Cohort study

  37. Rheumatology (Oxford)

    Temporal and regional variation in the use of biologic and targeted synthetic DMARDs for rheumatoid arthritis: a nationwide cohort study

    Cohort study

  38. Arthritis Res Ther

    Integrated multi-omics revealed that dysregulated lipid metabolism played an important role in RA patients with metabolic diseases

    Mechanistic study

  39. Arthritis Res Ther

    Infiltrations of plasma cells in synovium predict inadequate response to Adalimumab in Rheumatoid Arthritis patients

    Cohort study

  40. Semin Arthritis Rheum

    Real-world assessment of the efficacy and tolerability profile of JAK inhibitors in difficult-to-treat rheumatoid arthritis

    Cohort study

All 1,564 Briefs in ExploreShowing Briefs 681–720 of 1,564, newest first